Inventor
Shanzhong JIAN
Inventor
CN
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
C07KPeptides10%
PatentTitleYear
12,133,841Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof202411,548,868Heterocyclic compounds, compositions comprising heterocyclic compound, and methods of use thereof202311,242,334Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to JS INNOPHARM SHANGHAI LTD (2)· patent assignee history
2022–2024Based in CN· patent location history
2024Patents assigned to JS INNOMED HOLDINGS LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JS INNOPHARM SHANGHAI LTD | 2 | 2022–2023 |
| JS INNOMED HOLDINGS LTD | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 3 | 2022–2024 |